Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

Rhea-AI Summary

Lucid Diagnostics (Nasdaq: LUCD) will host a fourth quarter and full year 2025 business update conference call and webcast on March 26, 2026 at 8:30 AM ET. The call will feature CEO Lishan Aklog and CFO Dennis McGrath discussing operations and Q4 2025 financial results.

The webcast and 30-day replay will be available in the investor relations section at luciddx.com; dial-in numbers are provided for U.S. and international callers.

News Market Reaction – LUCD

-4.14%

1 alert

-4.14% News Effect

On the day this news was published, LUCD declined 4.14%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast at 8:30 AM ET

NEW YORK, March 12, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Thursday, March 26, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's fourth quarter 2025 financial results.

The webcast will be available at the investor relations section of the Company's website at luciddx.com.  Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at luciddx.com.

About Lucid Diagnostics

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-fourth-quarter-and-full-year-2025-business-update-conference-call-and-webcast-on-march-26-2026-302710091.html

SOURCE Lucid Diagnostics

FAQ

When will Lucid Diagnostics (LUCD) hold its Q4 and full year 2025 business update call?

The call is scheduled for March 26, 2026 at 8:30 AM ET. According to the company, the webcast and live dial-in will cover operations and Q4 2025 financial results presented by CEO and CFO.

How can investors access the Lucid Diagnostics (LUCD) webcast and replay?

Investors can watch the live webcast and a 30-day replay at luciddx.com investor relations. According to the company, a replay will be posted following the call and remain available for 30 days.

Who will present Lucid Diagnostics' (LUCD) March 26, 2026 business update?

CEO Lishan Aklog and CFO Dennis McGrath will present the business update. According to the company, Aklog will discuss operations and strategy while McGrath will review Q4 2025 financial results.

What phone numbers should U.S. and international listeners use for the LUCD conference call?

U.S. callers should dial 1-800-836-8184 and international listeners 1-646-357-8785. According to the company, callers should provide the conference name "Lucid Diagnostics Business Update" to join.

Will Lucid Diagnostics (LUCD) provide financial details during the March 26, 2026 call?

Yes. The company said the CFO will discuss the company's fourth quarter 2025 financial results during the call. According to the company, attendees can expect commentary on operations and financial performance.